Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study

por Pandit, Anuja, Bhalani, Nirav, Bhushan, B.L. Shashi, Koradia, Parshottam, Gargiya, Shweta, Bhomia, Vinay, Kansagra, Kevinkumar
Publicado 2021

Corrigendum to “Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study” [International Journal of Infectious...

por Pandit, Anuja, Bhalani, Nirav, Bhushan, B.L. Shashi, Koradia, Parshottam, Gargiya, Shweta, Bhomia, Vinay, Kansagra, Kevinkumar
Publicado 2021

Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study

por Bhushan B L, Shashi, Wanve, Sunil, Koradia, Parshottam, Bhomia, Vinay, Soni, Pravin, Chakraborty, Sisir, Khobragade, Akash, Joshi, Shashank, Mendiratta, Sanjeev Kumar, Kansagra, Kevin Kumar, Parihar, Anurag, Sharma, Sunil, Patel, Jatin
Publicado 2021